Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Ertugliflozin

    Client Email Product

    Ertugliflozin

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    11
    US DMFs Filed

    US DMFs Filed

    7
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    8
    API REF. PRICE (USD / KG)
    7,654

    API Market Place

    4
    INTERMEDIATES
    1
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    12
    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    6
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    15.00

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    191
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    24

    USFDA Exclusivities

    8
    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    25
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Hetero Labs Generic Ertugliflozin Receives Tentative Approval in US
    Hetero Labs Generic Ertugliflozin Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217071

    FDA
    17 Apr 2024
    Share Share
    Zenara's Generic Ertugliflozin Receives Approval in the U.S.
    Zenara's Generic Ertugliflozin Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216842

    FDA
    04 Apr 2023
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Ertugliflozin
    FDA Confirms Paragraph IV Patent Litigation for Ertugliflozin

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-ertugliflozin-1646027922.pdf

    FDA
    08 Feb 2022
    Share Share
    Ertugliflozin Reduces Likelihood of Insulin Initiation in Insulin-Naive Patients
    Ertugliflozin Reduces Likelihood of Insulin Initiation in Insulin-Naive Patients

    https://www.firstwordpharma.com/node/1841963?tsid=4

    FIRSTWORDPHARMA
    29 Jun 2021
    Share Share
    Merck's Steglatro shows limited promise with heart failure hospitalization data
    Merck's Steglatro shows limited promise with heart failure hospitalization data

    https://www.fiercepharma.com/pharma/esc-merck-s-steglatro-makes-case-for-heart-failure-new-hospitalization-data

    Kyle Blankenship FIERCEPHARMA
    31 Aug 2020
    Share Share
    Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Endpoint
    Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Endpoint

    https://investors.merck.com/news/press-release-details/2020/Merck-and-Pfizers-SGLT2-Inhibitor-STEGLATROTM-ertugliflozin-Meets-Primary-Endpoint-in-VERTIS-CV-Trial-for-Patients-with-Type-2-Diabetes-and-Atherosclerotic-Cardiovascular-Disease/default.aspx

    PRESS RELEASE
    17 Jun 2020
    Share Share
    ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart
    ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart

    https://www.fiercepharma.com/pharma/ada-merck-pfizer-s-steglatro-rings-up-cv-safety-win-but-it-still-lags-heart-helping-peers

    FIERCE PHARMA
    17 Jun 2020
    Share Share
    Steglatro rings up CV safety win but still lags SGLT2 peers
    Steglatro rings up CV safety win but still lags SGLT2 peers

    https://www.fiercepharma.com/pharma/ada-merck-pfizer-s-steglatro-rings-up-cv-safety-win-but-it-still-lags-heart-helping-peers

    Carly Helfand FIERCE PHARMA
    16 Jun 2020
    Share Share
    NICE recommendation for Steglatro in type II diabetes
    NICE recommendation for Steglatro in type II diabetes

    http://www.pharmatimes.com/news/nice_recommendation_for_steglatro_in_type_ii_diabetes_1282725

    Anna Smith PHARMA TIMES
    28 Mar 2019
    Share Share
    Diabetes drugs in SGLT2 inhibitor class linked to pancreatitis genital infection
    Diabetes drugs in SGLT2 inhibitor class linked to pancreatitis genital infection

    http://www.pharmabiz.com/NewsDetails.aspx?aid=114891&sid=1

    PHARMABIZ
    27 Mar 2019
    Share Share
    SMC OK's four meds for NHS use, including Roche's Perjeta
    SMC OK's four meds for NHS use, including Roche's Perjeta

    http://www.pharmatimes.com/news/smc_oks_four_meds_for_nhs_use,_including_roches_perjeta_1275014

    Anna Smith PHARMA TIMES
    15 Jan 2019
    Share Share
    How One Class Of Diabetes Meds May Lead To Flesh-Eating Genital Infections
    How One Class Of Diabetes Meds May Lead To Flesh-Eating Genital Infections

    https://www.forbes.com/sites/brucelee/2018/09/01/how-one-class-of-diabetes-medications-may-lead-to-flesh-eating-genital-infections/#62b120f17619

    Bruce Y. Lee FORBES
    01 Sep 2018
    Share Share
    FDA slaps gangrene warning on SGLT2 diabetes drugs
    FDA slaps gangrene warning on SGLT2 diabetes drugs

    https://www.fiercepharma.com/pharma/fda-slaps-new-gangrene-warning-popular-sglt2-diabetes-drugs-from-lilly-j-j-and-more

    Arlene Wb FIERCE PHARMA
    31 Aug 2018
    Share Share
    Prescription med: registration of new chemical entities in Australia
    Prescription med: registration of new chemical entities in Australia

    https://www.tga.gov.au/prescription-medicines-registration-new-chemical-entities-australia

    TGA
    09 Jul 2018
    Share Share
    Merck's Steglatro (ertugliflozin) Receives Approval In Europe
    Merck's Steglatro (ertugliflozin) Receives Approval In Europe

    https://www.pharmacompass.com/pdf/news/merck-sharp-dohmes-steglatro-ertugliflozin-receives-approval-in-europe-1523363293.pdf

    EMA
    06 Apr 2018
    Share Share
    MSD`s Segluromet (ertugliflozin/Metformin Hydrochloride) Receives Approval In Europe
    MSD`s Segluromet (ertugliflozin/Metformin Hydrochloride) Receives Approval In Europe

    https://www.pharmacompass.com/pdf/news/msds-segluromet-ertugliflozinmetformin-hydrochloride-receives-approval-in-europe-1523363573.pdf

    EMA
    06 Apr 2018
    Share Share
    Merck's Steglujan (ertugliflozin / sitagliptin) Receives Approval In Europe
    Merck's Steglujan (ertugliflozin / sitagliptin) Receives Approval In Europe

    https://www.ema.europa.eu/documents/overview/steglujan-epar-medicine-overview_en.pdf

    EMA
    05 Apr 2018
    Share Share
    Meeting highlights from the Committee for Medicinal Products Human Use (CHMP)
    Meeting highlights from the Committee for Medicinal Products Human Use (CHMP)

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/01/news_detail_002888.jsp&mid=WC0b01ac058004d5c1

    EMA
    26 Jan 2018
    Share Share
    EMA panel recommends Merck, Pfizer's diabetes drug
    EMA panel recommends Merck, Pfizer's diabetes drug

    https://www.reuters.com/article/us-merck-co-pfizer-ema/ema-panel-recommends-merck-pfizers-diabetes-drug-idUSKBN1FF1LU

    R. Rukmangadhan REUTERS
    26 Jan 2018
    Share Share
    US green light for Pfizer/Merck diabetes therapies
    US green light for Pfizer/Merck diabetes therapies

    http://www.pharmatimes.com/news/us_green_light_for_pfizermerck_diabetes_therapies_1215005

    Selina McKee PHARMA TIMES
    02 Jan 2018
    Share Share
    FDA’s year-end approvals take annual tally to 46
    FDA’s year-end approvals take annual tally to 46

    http://www.pmlive.com/pharma_news/fdas_year-end_approvals_take_annual_tally_to_46_1215003

    Phil Taylor PMLIVE
    02 Jan 2018
    Share Share
    How Large Is Merck's Phase 3 Drug Pipeline?
    How Large Is Merck's Phase 3 Drug Pipeline?

    http://www.nasdaq.com/article/how-large-is-mercks-phase-3-drug-pipeline-cm898499

    NASDAQ
    29 Dec 2017
    Share Share
    Diabetes Is Officially the Messiest Drug Market
    Diabetes Is Officially the Messiest Drug Market

    https://www.bloomberg.com/news/articles/2017-12-21/steglujan-fda-approval-messy-diabetes-market-gets-messier

    Max Nisen BLOOMBERG
    22 Dec 2017
    Share Share
    FDA Approves SGLT2 Inhibitor STEGLATRO™ Fixed-Dose Combination STEGLUJAN™
    FDA Approves SGLT2 Inhibitor STEGLATRO™ Fixed-Dose Combination STEGLUJAN™

    https://www.businesswire.com/news/home/20171222005054/en/FDA-Approves-SGLT2-Inhibitor-STEGLATRO%E2%84%A2-ertugliflozin-Fixed-Dose/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    22 Dec 2017
    Share Share
    U.S. FDA approves new diabetes drug from Merck and Pfizer
    U.S. FDA approves new diabetes drug from Merck and Pfizer

    https://uk.reuters.com/article/us-merck-co-pfizer-diabetes/u-s-fda-approves-new-diabetes-drug-from-merck-and-pfizer-idUKKBN1EE2QT?rpc=401&

    Toni Clarke REUTERS
    21 Dec 2017
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search